Healthcare provider profile · identity verified

Saira Beg, M.D.

Family Practice · PAHRUMP, NV · NPI 1275799819

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	505	175
Lisinopril	Lisinopril	382	119
Levothyroxine Sodium	Levothyroxine Sodium	336	106
Losartan Potassium	Losartan Potassium	306	101
Amlodipine Besylate	Amlodipine Besylate	265	92
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	251	56
Gabapentin	Gabapentin	191	66
Metformin Hcl	Metformin Hcl	184	61
Omeprazole	Omeprazole	184	67
Hydrochlorothiazide	Hydrochlorothiazide	176	55
Metoprolol Tartrate	Metoprolol Tartrate	159	58
Simvastatin	Simvastatin	122	38
Fluticasone Propionate	Fluticasone Propionate	111	58
Rosuvastatin Calcium	Rosuvastatin Calcium	111	43
Pantoprazole Sodium	Pantoprazole Sodium	109	42
Trazodone Hcl	Trazodone Hcl	108	33
Alprazolam	Alprazolam	107	28
Furosemide	Furosemide	107	43
Oxycodone Hcl	Oxycodone Hcl	106	18
Tamsulosin Hcl	Tamsulosin Hcl	105	36
Baclofen	Baclofen	103	36
Albuterol Sulfate Hfa	Albuterol Sulfate	101	50
Metoprolol Succinate	Metoprolol Succinate	101	34
Sertraline Hcl	Sertraline Hcl	93	25
Alendronate Sodium	Alendronate Sodium	88	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	88	21
Eliquis	Apixaban	81	27
Potassium Chloride	Potassium Chloride	79	31
Temazepam	Temazepam	77	11
Zolpidem Tartrate	Zolpidem Tartrate	75	15
Spironolactone	Spironolactone	72	25
Tramadol Hcl	Tramadol Hcl	71	22
Oxybutynin Chloride	Oxybutynin Chloride	66	24
Montelukast Sodium	Montelukast Sodium	63	26
Allopurinol	Allopurinol	60	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	18
Meloxicam	Meloxicam	59	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	59	14
Clopidogrel	Clopidogrel Bisulfate	57	20
Carvedilol	Carvedilol	51	21
Atenolol	Atenolol	50	16
Meclizine Hcl	Meclizine Hcl	50	17
Lovastatin	Lovastatin	48	16
Famotidine	Famotidine	45	19
Bupropion Hcl	Bupropion Hcl	43	11
Pravastatin Sodium	Pravastatin Sodium	43	14
Citalopram Hbr	Citalopram Hydrobromide	42	16
Tizanidine Hcl	Tizanidine Hcl	42	14
Prednisone	Prednisone	41	27
Symbicort	Budesonide/Formoterol Fumarate	38	14
Buspirone Hcl	Buspirone Hcl	37	14
Hydroxyzine Hcl	Hydroxyzine Hcl	36	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	27
Nifedipine Er	Nifedipine	35	14
Quetiapine Fumarate	Quetiapine Fumarate	35	17
Ropinirole Hcl	Ropinirole Hcl	35	12
Acyclovir	Acyclovir	34	12
Acetaminophen-Codeine	Acetaminophen With Codeine	33	12
Glipizide	Glipizide	33	12
Fluoxetine Hcl	Fluoxetine Hcl	32	11
Hydralazine Hcl	Hydralazine Hcl	32	14
Triamcinolone Acetonide	Triamcinolone Acetonide	32	14
Glimepiride	Glimepiride	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	13
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Jardiance	Empagliflozin	28	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Estradiol	Estradiol	27	suppressed
Ibuprofen	Ibuprofen	27	12
Lorazepam	Lorazepam	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	23
Xarelto	Rivaroxaban	26	suppressed
Ozempic	Semaglutide	25	suppressed
Topiramate	Topiramate	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Azithromycin	Azithromycin	22	19
Donepezil Hcl	Donepezil Hcl	21	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Diazepam	Diazepam	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Finasteride	Finasteride	19	suppressed
Nystatin	Nystatin	19	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Humulin N	Insulin Nph Human Isophane	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Lactulose	Lactulose	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Verapamil Hcl	Verapamil Hcl	14	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Primidone	Primidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error